AI-NATIVE WORKSPACE FOR BIOPHARMA
Raycaster keeps protocols, reports, Module 2/3, and quality docs in sync with the science, so your teams ship stronger submissions with far less rework.
Smarter tools, stronger submissions
Smarter tools,
stronger submissions.
Raycaster streamlines everything from regulatory research to drafting and impact analysis - so teams spend less time fighting documents and more time moving the molecule forward.
Raycaster reads across protocols, CSRs, Module 2/3, SOPs, and linked guidance. Ask a regulatory question in plain language and it surfaces regional requirements, impacted sections, and gaps—with citations back to the exact paragraphs.
Raycaster drafts protocols, amendments, IBs, CSRs, narratives, control strategies, validation reports, and key Module 2/3 sections from your templates and data. Writers stay in control, reviewing and refining instead of starting from a blank page.
Adjust an endpoint, limit, or process parameter and Raycaster shows every document it touches. It traces the impact across your dossier and proposes aligned updates, keeping protocols, reports, and modules in sync as the science evolves.
Built for the teams around the molecule
Raycaster meets drug
teams where they work.
From IND to lifecycle management, Raycaster adapts to how clinical, CMC, regulatory, and quality teams already get work done—so they can move faster without sacrificing control.
Keep protocols, amendments, IBs, CSRs, and narratives consistent with decisions and data—so writers spend time on interpretation, not reconciling versions.
Connect specs, control strategy, validation, and Module 3. When a process or limit changes, Raycaster shows the impact and drafts aligned updates across your CMC documentation.
Draft study reports, Module 2.4/2.6 summaries, and justifications grounded in ICH M3 and S-series guidance. When clinical plans shift, Raycaster shows which nonclinical studies are affected and helps update integrated summaries.
Trace every document back to its sources, keep SOPs and reports aligned with the latest requirements, and give auditors clear, navigable evidence of how changes were managed.
Our view of AI in regulated work
Documents should behave like part of the system, not like dead files.
Drug development still runs on documents that don't understand what they're describing. They don't know the molecule, the study, the guidance, or the other files they have to agree with. Every change becomes a scavenger hunt.
Raycaster was built by people who've lived the late-night rewrites and last-minute health authority questions. We don't believe AI should sit beside that process as a generic chatbot.
Instead, we're making the document itself intelligent—aware of its sources, its regulatory obligations, and its siblings across the dossier. So your teams can spend their time on judgment and science, not proving that every version still matches.
Every suggestion ties back to guidance, prior submissions, or data.
Experts review and approve; Raycaster drafts and traces.
Works across Vault, Word, Excel, and your existing stack.
See how Raycaster keeps every protocol, report, and module on the same path as your molecule—and gives your teams weeks back on every submission.
Drug development,
accelerated.
Don't miss out on Raycaster updates.
Company